The FDA has received 8,848 adverse event reports for dogs that name Prednisone.
- 8,848 reports name Prednisone in dogs, which is 0.9% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 53% are marked serious and 13% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 22% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, lethargy and diarrhoea.
- The FDA lists 1 approved animal drug application containing Prednisone for dogs.
- None of this is a rate. The FDA data does not record how many dogs were given Prednisone, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 4,645 | 53% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 1,122 | 13% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 1,978 | 22% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 377 | 4.3% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 3,031 | 34% | 21% |
Where on the body do the reported signs sit?
Not on the body: Whole body 22% Did not work 9.5%
- Stomach and gut35%vomiting, diarrhoea, weight loss, emesis and 3 more
- Whole body22%lethargy, death by euthanasia, lethargy, death and 1 more
- Blood and organ tests19%other abnormal test result, elevated alanine aminotransferase (alt), elevated serum alkaline phosphatase (sap), leucocytosis and 2 more
- Did not work9.5%lack of efficacy, lack of efficacy (endoparasite) - heartworm
- Thirst and urination6.6%polyuria, polydipsia
- Heart and breathing3.3%panting
- Brain and nerves2.5%seizure
- Behaviour2.3%behavioural disorder
Each figure is a share of sign mentions among the 25 signs reported most for Prednisone in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting1,334 15%
- Lethargy1,077 12%
- Diarrhoea982 11%
- Lack of efficacy795 9.0%
- Death by euthanasia689 7.8%
- Other abnormal test result637 7.2%
- Elevated alanine aminotransferase (ALT)551 6.2%
- Weight loss549 6.2%
Reports received per year
Is it approved for dogs?
The FDA lists 1 approved animal drug application containing Prednisone for dogs.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| MeticortenIntervet, Inc. | Liquid (Suspension) RX | Cat, Dog, Horse | 009-963 |
From the FDA record for Meticorten: Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. [continues in the FDA record]
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Prednisone in cats (752 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Gabapentin in dogs9,028
- Meloxicam in dogs8,083
- Firocoxib in dogs8,009
- Grapiprant in dogs7,776
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.